Dr. Yael Dishon Benattar
email: yael.dishon@gmail.com
Tel:
Cris:
Research Interests
Higher Education
Recent Publications
Research Interests
-
Antibiotic treatment for multidrug resistant Gram-negative organisms.
- Antibiotic treatment and antibiotic stewardship at end-of-life
Higher Education
Period of Study (month/year – month/year) | Name of Institution and Department | Degree |
10/1996-9/1999 | University of Haifa, English Language and Literature | B.A. |
10/2012-12/2014 | University of Haifa, The Cheryl Spencer Department of Nursing | M.A. (Dean’s honor) |
10/2015-8/2020 | University of Haifa, The Cheryl Spencer Department of Nursing | Ph.D. |
Recent Publications
- Kristoffersson AN, Brill MJ, Rognås V, Dishon Y, Durante-Mangoni E, Daitch V, Skiada A, Lellouche J, Nutman A, Kotsaki A, Andini R, Eliakim-Raz N, Bitterman R, Antoniadou A, Karlsson MO, Theuretzbacher U, Leibovici L, Daikos GL, Mouton JW, Carmeli Y, Paul M, Friberg LE (2020). Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria. Clinical Microbiology and Infection. 26(12):1644-1650
- Nutman A, Lellouche J, Temkin E, Daikos GL, Skiada A, Durante-Mangoni E, Dishon-Benattar Y, Bitterman R, Yahav D, Daitch V, Bernardo M, Iossa D, Zusman O, Friberg, LE, Mouton JW, Theuretzbacher U, Leibovici L, Paul M, Carmeli Y, AIDA Study Group (2020). Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes. Clinical Microbiology and Infection. 26(9):1185-1191.
- Daitch V, Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Cavezza G, Adler A, Dickstein Y, Pavleas I, Zampino R, Bitterman R, Zayyad H, Koppel F, Zak-Doron Y, Levi I, Babich T, Turjeman A, Ben-Zvi H, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity (2021). BMC Infectious Diseases 21:309.
- Nutman A, Temkin E, Lellouche J, Rakovitsky N, Hameir A, Daikos G, Durante-Mangoni E, Pavleas I, Dishon Y, Petersiel N, Yahav D, Eliakim N, Bernardo M, Iossa D, Friberg LE, Theuretzbacher U, Leibovici L, Paul M, Carmeli Y; AIDA Study Group (2022). In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections. Clinical Microbiology and Infection 28(1):73-78.
- Frenk S, Temkin E, Lurie-Weinberger M, Keren-Paz A, Rov R, Rakovitsky N, Wullfhart L, Nutman A, Daikos G, Skiada A, Durante-Mangoni E, Dishon Benattar Y, Bitterman R, Yahav D, Daitch V, Bernardo M, Iossa D, Zusman O, Friberg L, Mouton J, Theuretzbacher U, Leibovici L, Geffen, Y, Gershon, R, Paul M, Carmeli Y. Large scale whole genome sequencing of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance. Journal of Antimicrobial Chemotherapy. 2022 Jan 25:dkac010. doi: 10.1093/jac/dkac010. Online ahead of print.
